Related Experiment Video
Updated: Jan 22, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Overview of methicillin resistant Staphylococcus aureus mediated bone and joint infections in India
Ram Prabhoo1, Ram Chaddha2, Rajagopalan Iyer3
1Department of Orthopedic Surgery, Mukund Hospital Mumbai, Maharashtra.
Abstract:
Staphylococcus aureus is the most common pathogen causing bone and joint infections (BJI). In India, prevalence of Methicillin resistant Staphylococcus aureus (MRSA) is increasing at an alarming rate and emerged as an important contributor towards the difficult to treat BJI. Currently available anti-MRSA agents have their own limitations with regards to reduced susceptibility as well as safety and tolerability. Furthermore, biofilms over the prosthesis with invariably multi-drug resistant strains leads to complex treatment processes. This necessitates the need to develop and screen new antibiotics against MRSA that can easily penetrate the deep pockets of infection and take care of the challenges discussed. This review aims to discuss on MRSA infection in bone and joint infection, current antibiotic regimen, its associated limitations, and finally, the need to develop new antibiotic therapy for effective management of patients with BJI.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) poses a growing challenge in bone and joint infections (BJI). New antibiotics are crucial to overcome treatment limitations and combat resistant strains effectively.
Area of Science:
- Infectious Diseases
- Orthopedics
- Pharmacology
Background:
- Staphylococcus aureus is a primary cause of bone and joint infections (BJI).
- The rising prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) in India complicates BJI treatment.
- Existing anti-MRSA drugs face challenges including reduced efficacy, safety concerns, and biofilm formation on prosthetics.
Purpose of the Study:
- To review the current landscape of MRSA in BJIs.
- To discuss the limitations of existing antibiotic regimens for MRSA-induced BJIs.
- To highlight the urgent need for novel antibiotic development against MRSA.
Main Methods:
- Literature review focusing on MRSA in bone and joint infections.
- Analysis of current antibiotic treatment strategies and their associated challenges.
- Discussion on the implications of antibiotic resistance and biofilm formation.
Main Results:
- MRSA is a significant and increasing pathogen in BJIs, particularly in India.
- Current anti-MRSA agents have limitations in efficacy, safety, and overcoming drug resistance.
- Biofilm formation on prosthetic devices exacerbates treatment complexity.
Conclusions:
- Effective management of MRSA-related BJIs requires addressing limitations of current therapies.
- Development of new antibiotics with improved penetration and activity against resistant strains is essential.
- Novel therapeutic strategies are needed to combat challenging MRSA infections in bone and joint settings.
More Related Videos
Related Concept Videos
Structural Joints: Synovial Joints
Structural Joints: Fibrous Joints
Suture
All the bones of the skull, except for the mandible, are joined to each other by a fibrous joint called a suture. The fibrous connective tissue found at a suture strongly unites the adjacent skull bones and thus helps to protect the brain and form the face. In...
Structural Joints: Cartilaginous Joints
There are two types of cartilaginous joints:
Synchondrosis
A synchondrosis ("joined by cartilage") is a cartilaginous joint where bones are connected by hyaline cartilage. Synchondrosis may be temporary...
Joints
Structural joint classifications are based on the material that makes up the joint as well as whether or not the joint contains a space between the bones. Joints are structurally classified as fibrous, cartilaginous, or synovial.
Fibrous Joints Are Immovable
The bones of a...
Introduction to Joints
Ankle Joint

